Literature DB >> 20064987

Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India.

Vijay P Singh1, Alok Ranjan, Roshan K Topno, Rakesh B Verma, Niyamat A Siddique, Vidya N Ravidas, Narendra Kumar, Krishna Pandey, Pradeep Das.   

Abstract

We estimated the level of under-reporting of visceral leishmaniasis (VL) cases by comparing the actual reported cases with those expected as estimated using age- and sex-stratified incidence proportions obtained in a cohort of 31,324 persons. The average incidence proportion of VL cases in study population was 5.7/1,000 (95% confidence interval [CI] = 4.88-6.54) and 1.09/1,000 persons (95% CI = 0.99-1.20) based on the reported cases in two primary health centers. The overall magnitude of VL cases not reported to the government agencies was higher by a factor 4.17 (95% CI = 3.75-4.63) than for reported cases. The levels of under-reporting were 4.74 (95% CI = 4.11-5.47) in males and 3.51 (95% CI = 2.99-4.11) in females with no significant difference (P > 0.05). It was significantly higher in persons >or= 30 years of age than in persons 30 years of age (P < 0.05).

Entities:  

Mesh:

Year:  2010        PMID: 20064987      PMCID: PMC2803501          DOI: 10.4269/ajtmh.2010.09-0235

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Socio-economics of visceral leishmaniasis in Bihar (India).

Authors:  C P Thakur
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Mar-Apr       Impact factor: 2.184

2.  Kala-azar--progress against a neglected disease.

Authors:  Henry W Murray
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

3.  Epidemiology of kala-azar in rural Bihar (India) using village as a component unit of study.

Authors:  R C Dhiman; A B Sen
Journal:  Indian J Med Res       Date:  1991-05       Impact factor: 2.375

4.  Changes in age incidence of kala-azar in India.

Authors:  D Basu; K K Mallik
Journal:  Indian J Public Health       Date:  1995 Jan-Mar

Review 5.  Leishmaniasis. Public health aspects and control.

Authors:  P Desjeux
Journal:  Clin Dermatol       Date:  1996 Sep-Oct       Impact factor: 3.541

6.  An estimate of kala azar in 1991 in district Vaishali and Bihar.

Authors:  D Bora; J Singh; J Bhattacharjee; V R Kureel; S Singh; R S Sharma
Journal:  J Commun Dis       Date:  1994-06

Review 7.  Epidemiology of visceral leishmaniasis in India.

Authors:  D Bora
Journal:  Natl Med J India       Date:  1999 Mar-Apr       Impact factor: 0.537

8.  Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).

Authors:  C P Thakur
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

9.  Human leishmaniases: epidemiology and public health aspects.

Authors:  P Desjeux
Journal:  World Health Stat Q       Date:  1992

Review 10.  Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Authors:  Philippe J Guerin; Piero Olliaro; Shyam Sundar; Marleen Boelaert; Simon L Croft; Philippe Desjeux; Monique K Wasunna; Anthony D M Bryceson
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

View more
  36 in total

1.  The economic value of a visceral leishmaniasis vaccine in Bihar state, India.

Authors:  Bruce Y Lee; Kristina M Bacon; Mirat Shah; Sara Beth Kitchen; Diana L Connor; Rachel B Slayton
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Management of visceral leishmaniasis in rural primary health care services in Bihar, India.

Authors:  E Hasker; S P Singh; P Malaviya; R P Singh; R Shankar; M Boelaert; S Sundar
Journal:  Trop Med Int Health       Date:  2010-07       Impact factor: 2.622

Review 3.  Social and Economic Burden of Human Leishmaniasis.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Am J Trop Med Hyg       Date:  2016-01-19       Impact factor: 2.345

4.  DDT-based indoor residual spraying suboptimal for visceral leishmaniasis elimination in India.

Authors:  Michael Coleman; Geraldine M Foster; Rinki Deb; Rudra Pratap Singh; Hanafy M Ismail; Pushkar Shivam; Ayan Kumar Ghosh; Sophie Dunkley; Vijay Kumar; Marlize Coleman; Janet Hemingway; Mark J I Paine; Pradeep Das
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 5.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

6.  Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs.

Authors:  Shri Prakash Singh; Siddhivinayak Hirve; M Mamun Huda; Megha Raj Banjara; Narendra Kumar; Dinesh Mondal; Shyam Sundar; Pradeep Das; Chitra Kumar Gurung; Suman Rijal; C P Thakur; Beena Varghese; Axel Kroeger
Journal:  PLoS Negl Trop Dis       Date:  2011-02-08

7.  Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008.

Authors:  Paritosh Malaviya; Albert Picado; Shri Prakash Singh; Epco Hasker; Rudra Pratap Singh; Marleen Boelaert; Shyam Sundar
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

8.  Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.

Authors:  Bart Ostyn; Kamlesh Gidwani; Basudha Khanal; Albert Picado; François Chappuis; Shri Prakash Singh; Suman Rijal; Shyam Sundar; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

9.  Identification and functional characterization of Leishmania donovani secretory peroxidase: delineating its role in NRAMP1 regulation.

Authors:  Nisha Singh; Surabhi Bajpai; Vinod Kumar; Jalaj K Gour; Rakesh K Singh
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

10.  The household costs of visceral leishmaniasis care in south-eastern Nepal.

Authors:  Surendra Uranw; Filip Meheus; Rob Baltussen; Suman Rijal; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.